Overview
Venture capital firm investing across technology and biotechnology, with portfolio exposure to cancer therapeutics, genomics, RNA medicines and healthcare professional networks.
Unlock the full profileGet the complete company dossier
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.